reshoring

News

Lilly has named Houston as the second of four locations for new manufacturing facilities that are central to a $27bn investment programme in the US.

News

Trump orders the FDA to ease the commissioning of domestic manufacturing facilities, as the regulator announces more unannounced foreign inspections.

News

The EU has proposed legislation to safeguard the supply of critical medicines but pharma and patient groups are concerned about the details.

News

Trump threatened tariffs if businesses do not reshore production to the US - and Lilly has now revealed a $27bn spend on new domestic facilities.

R&D

Questions of supply chain security and resiliency have been growing in recent years.